[1] ASAHARA T,MUROHARA T,SULLIVAN A,et al.Isolation of putative progenitor endothelial cells for angiogenesis[J].Science,1997,275(5302):964-967.
[2] NIESSNER A,HOHENSINNER P J,RYCHLI K,et al.Prognostic value of apoptosis markers in advanced heart failure patients[J].Eur Heart J,2009,30(7):789-796.
[3] BAUERSACHS J,WIDDER J D.Endothelial dysfunction in heart failure[J].Pharmacol Rep,2008,60(1):119-126.
[4] 黎叶飞,盛祖龙,姚玉宇,等.两种骨髓间充质干细胞移植途径治疗急性心肌梗死的比较研究[J].东南大学学报:医学版,2011,30(5):687-691.
[5] CRAENBROECK E M,HOYMANS V Y,BECKERS P J,et al.Exercise training improves function of circulating angiogenic cells in patients with chronic heart failure[J].Basic Res Cardiol,2010,105(5):665-676.
[6] CRAENBROECK E M,BECKERS P J,POSSEMIERS N M,et al.Exercise acutely reverses dysfunction of circulating angiogenic cells in chronic heart failure[J].Eur Heart J,2010,31(15):1924-1934.
[7] SCHWARTZENBERG S,AFEK A,CHARACH G,et al.Comparative analysis of the predictive power of different endothelial progenitor cell phenotypes on cardiovascular outcome[J].World J Cardiol,2010,2(9):299-304.
[8] CHANG H W,LEU S,SUN C K,et al.Level and value of circulating endothelial progenitor cells in patients with acute myocardial infarction undergoing primary coronary angioplasty:in vivo and in vitro studies[J].Transl Res,2010,156(4):251-263.
[9] FRITZENWANGER M,LORENZ F,JUNG C,et al.Differential number of CD34+,CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure[J].Eur J Med Res,2009,14(3):113-117.
[10] BALCONI G,LEHMANN R,FIORDALISO F,et al.Levels of circulating pro-angiogenic cells predict cardiovascular outcomes in patients with chronic heart failure[J].J Card Fail,2009,15(9):747-755.
[11] KISSEL C K,LEHMANN R,ASSMUS B,et al.Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure[J].J Am Coll Cardiol,2007,49(24):2341-2349.
[12] VALGIMIGLI M,RIGOLIN G M,FUCILI A,et al.CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure[J].Circulation,2004,110(10):1209-1212.
[13] KRENNING G,LUYN M J,HARMSEN M C.Endothelial progenitor cell-based neovascularization:implications for therapy[J].Trends Mol Med,2009,15(4):180-189.
[14] SEN S,MCDONALD S P,COARES P T,et al.Endothelial progenitor cells:novel biomarker and promising cell therapy for cardiovascular disease[J].Clin Sci(Lond),2011,120(7):263-283.
[15] 吴雪晖,罗飞,何清义,等.血管内皮祖细胞研究进展[J].医学研究生学报,2008,21:981-985.
[16] WEMER N,KOSIOL S,SCHIEGL T,et al.Circulating endothelial progenitor cells and cardiovascular outcomes[J].N Engl J Med,2005,353(10):999-1007.
[17] LEONE A M,VALGIMIGLI M,GIANNICO M B,et al.From bone marrow to the arterial wall:the ongoing tale of endothelial progenitor cells[J].Eur Heart J,2009,30(8):890-899.
[18] MICHOWITZ Y,GOLDSTEIN E,WEXLER D,et al.Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure[J].Heart,2007,93(9):1046-1050. |